Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

May 13, 2014

284_dirs_2014-05-13_f6bfed9c-a6b4-4a9f-9fb0-d36eb84a7145.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-05-09

Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Health)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-09 Stock Option (right to buy) $58.2200 A 60523.0000 Acquired 2024-05-08 Common Stock (60523.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 587.8153 Indirect

Footnotes

F1: Includes shares acquired and dividends earned through April 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.

F2: The option vests in three equal annual installments beginning May 9, 2015.